 dopamine muscarinic cholinergic receptor densities caudate specimens parkinsonian patients Binding spiperone benzilate QNB hydrogen caudate tissue parkinsonian patients time cerebral transplantation homogeneous group patients responsive marked disability secondary clinical fluctuations short-duration responses medication-induced dyskinesias substantial doses levodopa patients bromocriptine pergolide Binding densities dopamine receptors spiperone binding group patients specimens autopsy control findings medication-induced receptor downregulation Parallel changes muscarinic cholinergic receptors QNB binding control values reduction muscarinic receptors due loss nigrostriatal terminals muscarinic receptors muscarinic receptors increased corticostriatal glutamatergic input cells present prominent levodopa-induced dyskinesias receptor deficits reflection widespread degenerative cerebral disease levodopa-refractory symptoms patients